Re-Xite BT Sublingual tablet
By Re-Xite BT
Rx
10 Sublingual tablet in a Strip

Composition
Methylcobalamin(1500mcg)

Manufacturer - Linux Laboratories
Plot no: 492, Viduthalai Nagar Extension Near JD Mahal, Pallavaram Thuraipakam Road S.Kulathur,Kovilambakkam, Chennai - 600 117

Expires on or after
August, 2025

liver
Limited information is currently available regarding the use of Re-Xite BT Sublingual tablet in individuals with liver disease. It is strongly recommended to consult your doctor before using this medication if you have any liver-related concerns.

kidney
Limited information is known on using Re-Xite BT Sublingual tablet in patients with kidney disease. Consult your doctor prior to use.

alcohol
Caution is advised when consuming alcohol with Re-Xite BT Sublingual tablet. Consult your doctor regarding alcohol use.

driving
When taking Re-Xite BT Sublingual tablet, it typically does not impact your driving ability.

pregnancy
Re-Xite BT Sublingual tablet may not be safe to use during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it. Consult your doctor before using.

breastfeeding
Re-Xite BT Sublingual tablet is safe for use during breastfeeding according to human studies. The drug is unlikely to pass into breastmilk in harmful amounts, making it safe for both mother and baby.
Habit Forming | No |
Chemical Class | Cobalamin Derivative |
Therapeutic Class | VITAMINS MINERALS NUTRIENTS |
Action Class | - |
₹75.5
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025